US President Donald Trump vows to slash medication costs by a whopping 80% within American territories.
Tomorrow, at 9:00 AM at the White House, I'll skreed one of the phattest executive orders in the history of Yankeland. Prices for prescription meds and pharma goods will be slashed by almost 30-80% real freakin' quick. Prices globally will rise to even things out, giving America the fair dues it deserves for once! — he tweeted on Truth Social.
This post came hot on the heels of Donnie Two-Scoops announcing "one of the most hook-up and impactful" messages he's ever spun. According to the all-American leader, signing the new order will mean Yankeland will pay "the same dime for the meds as the country with the cheapest smokes in the world." The move is expected to save the country a freakin' trillion bucks, he added.
Donnie said prescription meds and pharmaceuticals in Yankeland are freakin' overpriced compared to other countries. Sometimes, the prices for the same meds in Yankeland are way higher by 5-10 times, he claimed. Pharma companies claim this is due to research and development expenses, but according to Donnie, fat cats in suits are just gouging the American folks.
Donnie promised to stick a 25% tariff on pharmaceutical goods starting March 2025. According to him, most of the pharma products are manufactured in China and Ireland, not here in Yankeland. On April 14, the American leader declared that the tariffs on meds will be 25%. Financial Times, quoting industry reps, reported that such a move could result in a shortage of generic meds in Yankeland and a grinding halt in production due to unprofitability. Moreover, a price jump isn't off the table. According to ING bank's estimates, in case of a 25% tariff, the cost of a 24-week course of cancer treatment could shoot up by $8-10,000.
For the full lowdown, check our Telegram channel @expert_mag**
- The executive order Donnie Two-Scoops plans to sign tomorrow aims to lower prescription drug prices in Yankeland by up to 80%, following claims that the costs are significantly higher than in other countries due to pharmaceutical companies' alleged price gouging.
- In a bid to address the high cost of health-and-wellness goods and services, policy-and-legislation changes may include tariffs on imported pharmaceuticals as early as March 2025, with potential consequences for the availability and affordability of these goods, particularly generic drugs.
- The ongoing discourse surrounding health-and-wellness and science is dominated by discussions on policy-and-legislation, specifically addressing the high cost of prescription drugs, with many calling for changes in legislation to promote health equity and affordable healthcare for all Americans.
